scholarly article | Q13442814 |
P356 | DOI | 10.1097/00000658-200302000-00015 |
P698 | PubMed publication ID | 12560784 |
P2093 | author name string | Sheung-Tat Fan | |
John Wong | |||
Ting-Bo Liang | |||
Irene Oi-Lin Ng | |||
Terence Kin-Wah Lee | |||
Kwan Man | |||
Chi-Leung Liu | |||
Chung-Mau Lo | |||
Zhi-Wei Zhang | |||
Peter Chin-Wan Fung | |||
Steven Hung-Teng Tsui | |||
P2860 | cites work | Small graft for living donor liver transplantation | Q28362695 |
A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
Study of donor-recipient liver size match for transplantation | Q30466933 | ||
Renal proliferative arteriopathies and associated glomerular changes: a light and electron microscopic study | Q33504792 | ||
Role of microcirculation in hepatic ischemia/reperfusion injury. | Q33702470 | ||
Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice | Q33749161 | ||
Endogenous nitric oxide synthesis: biological functions and pathophysiology | Q33814359 | ||
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury | Q33902524 | ||
A formula to estimate the approximate surface area if height and weight be known. 1916. | Q34437560 | ||
Nitric oxide modulation of focal adhesions in endothelial cells | Q40949467 | ||
Hsp70 chaperone systems: diversity of cellular functions and mechanism of action | Q41752367 | ||
Protective effect of heat preconditioning of rat liver graft resulting in improved transplant survival | Q43605133 | ||
Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury | Q43613012 | ||
Heme oxygenase-1 protects against vascular constriction and proliferation | Q43625670 | ||
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. | Q46664890 | ||
Small-for-size grafts in living-related liver transplantation | Q47214528 | ||
Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes | Q47216526 | ||
Impact of graft size mismatching on graft prognosis in liver transplantation from living donors | Q47271534 | ||
A correlated study of the fine structure and physiology of the perfused rat liver | Q47889240 | ||
Calculation of child and adult standard liver volume for liver transplantation. | Q52342275 | ||
Adult-to-Adult Living Donor Liver Transplantation Using Extended Right Lobe Grafts | Q58236287 | ||
MINIMUM GRAFT VOLUME FOR SUCCESSFUL ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE | Q58236334 | ||
Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances | Q72271861 | ||
Evidence that portal vein decompression improves survival of canine quarter orthotopic liver transplantation | Q72287867 | ||
Endothelin-1 induces direct constriction of hepatic sinusoids | Q72411025 | ||
Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft | Q73355906 | ||
A protective player in the vascular response to injury | Q73954816 | ||
The effects of splenic artery ligation in an experimental model of secondary hypersplenism | Q73956773 | ||
Prior induction of heat shock proteins by a nitric oxide donor attenuates cardiac ischemia/reperfusion injury in the rat | Q74052942 | ||
Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients | Q74452983 | ||
Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1 | Q74631271 | ||
Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia | Q77212324 | ||
Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1 | Q77827403 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liver transplantation | Q1368191 |
hemodynamics | Q1642137 | ||
P304 | page(s) | 256-264 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression | |
P478 | volume | 237 |
Q36523507 | Application of Induced Pluripotent Stem Cells in Liver Diseases |
Q38438725 | Assessment of right liver graft perfusion effectiveness between one and two-catheter infusion methods |
Q45016019 | Attenuation of small-for-size liver graft injury by FTY720: significance of cell-survival Akt signaling pathway. |
Q36111140 | Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma? |
Q37145514 | Cellular liver regeneration after extended hepatic resection in pigs |
Q40644081 | Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation |
Q55037451 | Clinical implication of hepatic volumetry for living donor liver transplantation. |
Q50002580 | Comparison of Regeneration of Remnant Liver After Hemihepatectomy with or Without the Middle Hepatic Vein |
Q36926615 | Deceased-donor split-liver transplantation in adult recipients: is the learning curve over? |
Q47371856 | Determinants of hospital mortality of adult recipients of right lobe live donor liver transplantation |
Q36123284 | Dual-Purpose Bioreactors to Monitor Noninvasive Physical and Biochemical Markers of Kidney and Liver Scaffold Recellularization |
Q33421276 | Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation. |
Q41817590 | Early Graft Dysfunction in Living Donor Liver Transplantation and the Small for Size Syndrome |
Q37362874 | Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes. |
Q46731329 | Effect of the portacaval shunt on reperfusion injury after 65% hepatectomy in pigs. |
Q33719955 | Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation |
Q58570352 | Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence |
Q41688113 | Establishing a Porcine Model of Small for Size Syndrome following Liver Resection |
Q90661851 | Evaluation of the role of transhepatic flow in postoperative outcomes following major hepatectomy (THEFLOW): study protocol for a single-centre, non-interventional cohort study |
Q47300684 | FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway. |
Q45214556 | FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. |
Q47114724 | Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence |
Q34405116 | Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection |
Q46967688 | Hepatocyte dynamics in a three-dimensional rotating bioreactor |
Q40136744 | Historical perspective of living donor liver transplantation |
Q26766049 | Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients |
Q37366919 | Influence of portosystemic shunt on liver regeneration after hepatic resection in pigs |
Q33212247 | Ischemic preconditioning impairs liver regeneration in extended reduced-size livers |
Q57066918 | Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong |
Q38168828 | Liver function impairment in liver transplantation and after extended hepatectomy |
Q61045905 | Liver transplantation for hepatocellular carcinoma |
Q28073940 | Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor |
Q88979476 | Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure? |
Q44669532 | Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts |
Q89953527 | Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma |
Q79925691 | Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patients |
Q34263346 | Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma |
Q26997063 | Management of recurrent hepatocellular carcinoma after liver transplant |
Q46739710 | Maximizing venous outflow after right hepatic living donor liver transplantation with a venous graft patch. |
Q43540063 | Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein |
Q64328743 | Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center |
Q34601591 | Posterior cavoplasty: a new approach to avoid venous outflow obstruction and symptoms for small-for-size syndrome in right lobe living donor liver transplantation |
Q37280357 | Pretreatment of Small-for-Size Grafts In Vivo by γ -Aminobutyric Acid Receptor Regulation against Oxidative Stress-Induced Injury in Rat Split Orthotopic Liver Transplantation |
Q24309608 | Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation |
Q47308949 | Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation |
Q37823542 | Regulation of hepatic blood flow: the hepatic arterial buffer response revisited |
Q38125626 | Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT. |
Q36889221 | Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury |
Q46728701 | Safety limit of the extent of hepatectomy for rats with moderately fatty liver: experimental study concerning living liver donor safety |
Q34977062 | Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation |
Q34563749 | Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience |
Q53588822 | Significance of CT attenuation value in liver grafts following right lobe living-donor liver transplantation. |
Q42395923 | Small-for-size syndrome in adult-to-adult living-related liver transplantation |
Q38217423 | Small-for-size syndrome in living-donor liver transplantation using a left lobe graft |
Q46920608 | Splenic artery ligation ameliorates hepatic ischemia and reperfusion injury in rats |
Q42168904 | Splenic artery ligation improves remnant liver function in partially hepatectomized rats with ischemia/reperfusion injury |
Q47262575 | Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series |
Q38700048 | The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation |
Q40123406 | The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence. |
Q82104029 | [Small-for-size: experimental findings for liver surgery] |
Search more.